Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
0.2852
USD
-7.7%
Market Closed
Market Cap:
$15.1m
Balance Sheet
Balance Sheet Decomposition
Iterum Therapeutics PLC
Iterum Therapeutics PLC
Balance Sheet Decomposition is not available for
Iterum Therapeutics PLC
Iterum Therapeutics PLC
Balance Sheet
Iterum Therapeutics PLC
Iterum Therapeutics PLC
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
25
|
8
|
45
|
5
|
15
|
27
|
21
|
6
|
24
|
|
| Cash Equivalents |
25
|
8
|
45
|
5
|
15
|
27
|
21
|
6
|
24
|
|
| Short-Term Investments |
0
|
32
|
41
|
1
|
2
|
54
|
40
|
18
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
3
|
7
|
6
|
5
|
2
|
1
|
2
|
1
|
|
| Total Current Assets |
26
|
44
|
93
|
12
|
21
|
83
|
62
|
26
|
25
|
|
| PP&E Net |
0
|
1
|
1
|
8
|
6
|
4
|
2
|
1
|
0
|
|
| PP&E Gross |
0
|
1
|
1
|
8
|
6
|
4
|
2
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
0
|
20
|
|
| Other Long-Term Assets |
1
|
2
|
4
|
6
|
6
|
1
|
1
|
0
|
0
|
|
| Total Assets |
27
N/A
|
47
+74%
|
98
+109%
|
26
-74%
|
33
+27%
|
92
+179%
|
67
-27%
|
26
-61%
|
45
+70%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
3
|
4
|
15
|
1
|
1
|
3
|
5
|
0
|
|
| Accrued Liabilities |
3
|
4
|
7
|
13
|
2
|
2
|
5
|
8
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
6
|
6
|
2
|
0
|
0
|
14
|
|
| Other Current Liabilities |
0
|
0
|
0
|
3
|
32
|
9
|
2
|
0
|
0
|
|
| Total Current Liabilities |
4
|
7
|
12
|
37
|
42
|
13
|
9
|
14
|
18
|
|
| Long-Term Debt |
0
|
0
|
13
|
8
|
36
|
25
|
28
|
19
|
31
|
|
| Other Liabilities |
0
|
0
|
1
|
7
|
6
|
3
|
1
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
7
+71%
|
26
+264%
|
52
+98%
|
83
+60%
|
41
-50%
|
39
-6%
|
33
-16%
|
49
+49%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
55
|
132
|
235
|
287
|
378
|
423
|
461
|
486
|
|
| Additional Paid In Capital |
48
|
94
|
203
|
209
|
236
|
427
|
451
|
455
|
482
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
23
N/A
|
40
+74%
|
72
+81%
|
26
N/A
|
51
-93%
|
50
N/A
|
28
-44%
|
6
N/A
|
4
+36%
|
|
| Total Liabilities & Equity |
27
N/A
|
47
+74%
|
98
+109%
|
26
-74%
|
33
+27%
|
92
+179%
|
67
-27%
|
26
-61%
|
45
+70%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
3
|
12
|
13
|
13
|
32
|
|
Switch to:
Switch to:
See Also
Discover More
